1. Introduction {#sec1-marinedrugs-15-00139}
===============

The genus *Talaromyces* (Trichocomaceae), a sexual state of *Penicillium*, is important because of its ubiquity. They have been isolated from soil, plants, sponges and foods \[[@B1-marinedrugs-15-00139]\]. The fungi of this genus produce a wide variety of secondary metabolites including alkaloids, peptides, lactones, polyketides, and miscellaneous structural type of compounds \[[@B2-marinedrugs-15-00139]\]. Recently, we have reported the isolation of wortmin, *meso*-1,4-*bis*(4-methoxybenzyl)-2,3-butanediol and a new isocoumarin derivative tratenopyrone from the ethyl acetate extract of the culture of *Talaromyces tratensis* KUFA 0091, isolated from the marine sponge *Mycale* sp., collected from the Gulf of Thailand \[[@B3-marinedrugs-15-00139]\]. During our ongoing research on secondary metabolites from marine-derived fungi with potential anti-obesity activity, we have investigated the secondary metabolites of a Thai collection of *T. stipitatus* KUFA 0207, isolated from the marine sponge *Stylissa flabelliformis*, collected from the coral reef at Samaesarn Island in the Gulf of Thailand. The ethyl acetate extract of the culture of this fungus furnished, in addition to two new compounds including a new analog of ergosterol: talarosterone (**1**) and a new *bis*-anthraquinone derivative (**3**), palmitic acid and the previously reported ergosta-4,6,8(14),22-tetraen-3-one \[[@B4-marinedrugs-15-00139]\], ergosterol 5,8-endoperoxide \[[@B5-marinedrugs-15-00139]\], cyathisterone (**2**) \[[@B6-marinedrugs-15-00139]\], emodin (**4a**) \[[@B7-marinedrugs-15-00139]\], questinol (**4b**) \[[@B8-marinedrugs-15-00139]\], citreorosein (**4c**) \[[@B7-marinedrugs-15-00139]\], fallacinol (**4d**) \[[@B9-marinedrugs-15-00139]\], rheoemodin (**4e**) \[[@B10-marinedrugs-15-00139]\], and secalonic acid A (**5**) \[[@B11-marinedrugs-15-00139],[@B12-marinedrugs-15-00139]\] ([Figure 1](#marinedrugs-15-00139-f001){ref-type="fig"}).

Obesity is increasing at an alarming rate and only a few medications are currently on the market \[[@B13-marinedrugs-15-00139]\]. Recent researches demonstrated that many natural products, including secondary metabolites from plants, cyanobacteria, fungi and phytoplankton, possess anti-obesity activities \[[@B14-marinedrugs-15-00139],[@B15-marinedrugs-15-00139]\]. Although many phenolic compound-containing plant extracts and several of their phenolic constituents such as flavonoids have been demonstrated to have potential as anti-obesity agents with different modes of action \[[@B15-marinedrugs-15-00139]\], only a few anthraquinones have been investigated for their anti-obesity potential. Huang et al. \[[@B16-marinedrugs-15-00139]\] have patented (US 8247001 B2) the anti-obesity product and the method of preparation of the alcohol extract of *Cassia obtusifolia* seeds, which contains the anthraquinones aurantio-obtusin, obtusifolin and their glycosides, for use in the treatment of obesity and related metabolic and liver diseases. Tzeng et al. \[[@B17-marinedrugs-15-00139]\], in their investigation of the anti-obesity and antihyperlipidaemic effects of emodin, have found that this anthraquinone caused dose-related reductions in the hepatic triglyceride and cholesterol contents and lowered hepatic lipid droplets accumulation in high-fat diet-fed rats. In order to investigate the potential of anthraquinone-producing marine fungi as a source of anti-obesity compounds, anthraquinones **4a**--**e** and secalonic acid A (**5**) were evaluated for their anti-obesity activity using the zebrafish Nile red assay. Zebrafish is gaining popularity as a screening system for bioactive compounds with the advantages of a small whole animal model, and higher physiological relevance over cellular in vitro models \[[@B18-marinedrugs-15-00139]\]. The zebrafish larvae Nile red assay is suitable to detect anti-obesogenic activities since zebrafish larvae were demonstrated to respond to known lipid regulator drugs similarly as humans \[[@B19-marinedrugs-15-00139]\].

2. Results and Discussion {#sec2-marinedrugs-15-00139}
=========================

The molecular formula C~28~H~40~O~3~ of compound **1**, a white crystal (mp, 145--148 °C), was established based on the (+)-HRESIMS *m*/*z* 425.3056 \[M + H\]^+^ (calculated 425.3056), indicating nine degrees of unsaturation. The IR spectrum showed absorption bands for conjugated ketone carbonyl (1689, 1670 cm^−1^) and olefin (1593 cm^−1^) groups. The ^1^H and ^13^C NMR spectra ([Table 1](#marinedrugs-15-00139-t001){ref-type="table"}, [Supplementary Information, Figures S1 and S2](#app1-marinedrugs-15-00139){ref-type="app"}) of **1** showed similar characteristics of ergosterol derivatives. The ^13^C NMR spectrum of **1** showed the presence of twenty-eight carbon signals which can be classified, by DEPTs and HSQC spectra ([Supplementary Information, Figure S4](#app1-marinedrugs-15-00139){ref-type="app"}), as two conjugated ketone carbonyl (δ~C~ 199.5 and 195.9), one quaternary sp^2^ (δ~C~ 155.0), three methine sp^2^ (δ~C~ 135.0, 132.5, 129.2), one oxyquaternary sp^3^ (δ~C~ 66.2), two quaternary sp^3^ (δ~C~ 44.3, 36.8), seven methine sp^3^ (δ~C~ 56.1, 56.0, 51.8, 43.9, 42.8, 40.0, 33.0), six methylene sp^3^ (δ~C~ 39.0, 37.1, 33.8, 27.7, 20.7, 18.7), two tertiary methyl (δ~C~ 21.8, 12.4) and four secondary methyl (δ~C~ 21.0, 20.0, 19.6, 17.6) groups. The ^1^H NMR spectrum ([Table 1](#marinedrugs-15-00139-t001){ref-type="table"}, [Supplementary Information, Figure S1](#app1-marinedrugs-15-00139){ref-type="app"}) exhibited a doublet of an olefinic proton at δ~H~ 6.66 (*J* = 0.8 Hz), a singlet of one proton at δ~H~ 3.20, two singlets of the tertiary methyls at δ~H~ 1.50 and 0.89, in addition to the proton signals of the (3*E*)-5,6-dimethylhept-3-en-2-yl side chain \[δ~H~ 0.82, d, *J* = 6.8 Hz (H~3~-27), δ~H~ 0.84, d, *J* = 6.8 Hz (H~3~-28), δ~H~ 1.04, d, *J* = 6.8 Hz (H~3~-21), δ~H~ 5.15, dd, *J* = 15.3, 7.3 Hz (H-22) and δ~H~ 5.25, dd, *J* = 15.3, 8.0 Hz (H-23)\]. As both H~3~-21 and the methyl singlet at δ~H~ 0.89 showed HMBC cross peaks to C-17 (δ~C~ 56.0), the methyl singlet at δ~H~ 0.89 was assigned to CH~3~-18. Therefore, another methyl singlet (δ~H~ 1.50, δ~C~ 21.8) was assigned to CH~3~-19. Since the HMBC spectrum ([Table 1](#marinedrugs-15-00139-t001){ref-type="table"} and [Figure 2](#marinedrugs-15-00139-f002){ref-type="fig"}, [Supplementary Information, Figure S5](#app1-marinedrugs-15-00139){ref-type="app"}) also exhibited cross peaks from both H~3~-19 and the doublet of the olefinic proton at δ~H~ 6.66 (*J* = 0.8 Hz, H-4) to the quaternary sp^2^ carbon at δ~C~ 155.0, the double bond was placed between C-4 (δ~C~ 129.2) and C-5 (δ~C~ 155.5). Moreover, H~3~-19 also showed HMBC cross peaks to the carbon signals at δ~C~ 43.9, 37.1 and 36.8, therefore, they were assigned to C-9, C-1 and C-10, respectively. On the other hand, the carbons at δ~C~ 44.3 and 51.8 were assigned to C-13 and C-14 since they both showed HMBC cross peaks to H~3~-18. Moreover, since the HMBC spectrum ([Table 1](#marinedrugs-15-00139-t001){ref-type="table"} and [Figure 2](#marinedrugs-15-00139-f002){ref-type="fig"}, [Supplementary Information, Figure S5](#app1-marinedrugs-15-00139){ref-type="app"}) also exhibited cross peaks from the singlet at δ~H~ 3.20 to C-5, C-14, the carbons at δ~C~ 66.2 and δ~C~ 195.9, the carbon at δ~C~ 66.2 was assigned to C-8 and one of the conjugated carbonyl (δ~C~ 195.9) was placed on C-6. This was supported by the HMBC cross peak from H-4 to C-6. Therefore, another conjugated carbonyl group (δ~C~ 199.5) must be on C-3. The fact that there was one more oxygen atom to be accounted for, along with the presence of the oxyquaternary carbon (δ~C~ 66.2), the epoxide function was placed between C-7 and C-8. Therefore, the structure of **1** was elucidated as 7,8-epoxyergosta-4,22-dien-3,6-dione.

In order to determine the stereochemistry of **1**, the ROESY spectrum was obtained. As the ROESY spectrum ([Table 1](#marinedrugs-15-00139-t001){ref-type="table"} and [Figure 3](#marinedrugs-15-00139-f003){ref-type="fig"}, [Supplementary Information, Figure S7](#app1-marinedrugs-15-00139){ref-type="app"}) showed cross peaks from H-7 to H-9, H-14 and H-15, but not to H~3~-19, it was concluded that the epoxide ring was on the same face as CH~3~-19, i.e., the relative configuration of C-7 and C-8 is 7*R* and 8*R* respectively.

Since compound **1** was obtained in a suitable crystal, X-ray analysis was carried out, and the ORTEP view shown in [Figure 4](#marinedrugs-15-00139-f004){ref-type="fig"} revealed that the absolute configuration of C-7, C-8, C-9, C-10, C-13, C-14, C-17, C-20 and C-24 is 7*R*, 8*R*, 9*R*, 10*R*, 13*R*, 14*R*,17*R*, 20*S*, 24*R*. A literature search indicated that **1** has never been previously reported. Therefore, it is a new compound and was named talarosterone.

The ^1^H, ^13^C NMR, IR and HRMS data of **2** ([Supplementary information, Table S1](#app1-marinedrugs-15-00139){ref-type="app"}, [Figures S8--S12](#app1-marinedrugs-15-00139){ref-type="app"}) are compatible with those reported for cyathiserone \[[@B6-marinedrugs-15-00139]\]. The structure and the stereochemistry of **2** were confirmed by X-ray analysis and the ORTEP view is shown in [Figure 5](#marinedrugs-15-00139-f005){ref-type="fig"}.

Compound **3** was isolated as a reddish orange solid (mp, 258--260 °C). The IR spectrum showed absorption bands for hydroxyl (3463 cm^−1^), conjugated ketone carbonyl (1622 cm^−1^) and aromatic (1550 cm^−1^) groups. The ^13^C NMR spectrum ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"}, [Supplementary Information, Figure S14](#app1-marinedrugs-15-00139){ref-type="app"}) exhibited fifteen carbon signals which, in conjunction with DEPTS and HSQC spectra ([Supplementary Information, Figure S16](#app1-marinedrugs-15-00139){ref-type="app"}), can be categorized as two conjugated ketone carbonyls (δ~C~ 189.6 and 182.1), nine quaternary sp^2^ (δ~C~ 164.4, 164.3, 161.1, 148.2, 133.2, 131.3, 123.5, 113.1, 108.9), three methine sp^2^ (δ~C~ 123.6, 120.5, 107.2) and one tertiary methyl (δ~C~ 21.5) groups. The ^1^H NMR spectrum ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"}, [Supplementary Information, Figure S13](#app1-marinedrugs-15-00139){ref-type="app"}) showed one singlet at δ~H~ 6.73 and two double doublets at δ~H~ 7.15 (*J* = 1.0, 0.5 Hz) and 7.28 (*J* = 1.0, 0.5 Hz) of the aromatic protons and one singlet of the tertiary methyl (δ~H~ 2.33), in addition to two singlets of the hydrogen-bonded hydroxyl groups at δ~H~ 12.04 and δ~H~ 12.79.

The ^1^H and ^13^C NMR features suggested that **3** was a polyhydroxy methyl anthraquinone. That one of the benzene rings of **3** was a 3-hydroxy-5-methyl-1,2,3,5-tetrasubstituted was supported by the COSY correlations ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"} and [Figure 6](#marinedrugs-15-00139-f006){ref-type="fig"}, [Supplementary Information, Figure S15](#app1-marinedrugs-15-00139){ref-type="app"}) of the aromatic protons at δ~H~ 7.15 (*J* = 1.0, 0.5 Hz, H-6) and 7.28 (*J* = 1.0, 0.5 Hz, H-8) with the methyl protons at δ~H~ 2.33 as well as by the HMBC correlations from H-6 to C-8 (δ~C~ 120.5), C-5 (δ~C~ 161.1), C-10a (δ~C~ 113.1), and CH~3~-7 (δ~C~ 21.5), from H-8 to C-6 (δ~C~ 123.6), C-10a and CH~3~-7 as well as from OH-5 (δ~H~ 12.04, s) to C-5, C-6 and C-10a ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"} and [Figure 6](#marinedrugs-15-00139-f006){ref-type="fig"}, [Supplementary Information, Figure S17](#app1-marinedrugs-15-00139){ref-type="app"}). Since the methyl protons showed HMBC correlation with the carbon at δ~C~ 148.2, it was assigned to C-7. On the other hand, another benzene ring of **3** was 3, 6-dihydroxy-1,2,3,5,6-substituted since the HMBC spectrum ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"} and [Figure 6](#marinedrugs-15-00139-f006){ref-type="fig"}, [Supplementary Information, Figure S17](#app1-marinedrugs-15-00139){ref-type="app"}) exhibited correlations from the aromatic proton singlet at δ~H~ 6.73 (H-3) to C-1 (δ~C~ 164.3), C-4 (δ~C~ 164.4), C-4a (δ~C~ 108.9) as well as from the hydroxyl singlet at δ~H~ 12.79 (OH-4) to C-3 (δ~C~ 107.2), C-4 (δ~C~ 164.4) and C-4a (δ~C~ 108.9). Moreover, the HMBC spectrum ([Table 2](#marinedrugs-15-00139-t002){ref-type="table"} and [Figure 6](#marinedrugs-15-00139-f006){ref-type="fig"}, [Supplementary Information, Figure S17](#app1-marinedrugs-15-00139){ref-type="app"}) also exhibited a cross peak from H-8 to the carbonyl carbon at δ~C~ 182.1, the latter was assigned to C-9. Since, there was no cross peak from H-3 to either of the carbonyl carbons, the carbonyl carbon at δ~C~ 189.6 was assigned to C-10. The higher chemical shift value of C-10 than that of C-9 was justified by its hydrogen bonding with both OH-4 and OH-5. By comparing the ^13^C NMR data of **3** to those of other anthraquinones isolated from this fungus, i.e., emodin (**4a**), citreorosein (**4c**), fallacinol (**4d**) and rheoemodin (**4e**), the carbons at δ~C~ 131.3 and δ~C~ 133.2 were assigned to C-8a and C-9a, respectively. Therefore, the structure of **3** was tentatively established as 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. However, this structure (C~15~H~9~O~5~) was not complete since there was no substituent on C-2 (δ~C~ 123.5) to be accounted for. Since the (+)-HRESIMS of **3** gave the \[M + H\]^+^ peak at *m*/*z* 539.0942 \[M + H\]^+^, corresponding to C~30~H~19~O~10~ (calculated 539.0978), the molecular formula of **3** was C~30~H~18~O~10~ (twenty-two degrees of unsaturation). Therefore, the structure of **3** was a dimer of 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. This structure was also supported by the HMBC correlation from H-2 to the quaternary sp^2^ carbon at δ~C~ 123.5 (C-2′). Therefore, the structure of **3** was established as 2, 2′-*bis*-(7-methyl-1,4,5-trihydroxy-anthracene-9,10-dione).

Literature search revealed that Tan et al. \[[@B20-marinedrugs-15-00139]\] have reported isolation of the structurally similar *bis*-anthraquinone, named 2240A, from an unidentified endophytic fungus (strain no 2240), isolated from the estuarine mangrove from the South China Sea Coast. The structure of 2240A is also a dimer of 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone; however, the two anthraquinone monomers are linked between C-3 and C-3′ instead of C-2 and C-2′ as in **3**. Surprisingly, the ^1^H and ^13^C NMR chemical shift values reported for 2240A by Tan et al. \[[@B20-marinedrugs-15-00139]\] were very similar to those of **3**. Although the structures of **3** and 2240A cannot be distinguished by HMBC correlations, careful analysis of the ^1^H and ^13^C NMR data of compound 2240A revealed that Tan et al. \[[@B20-marinedrugs-15-00139]\] assigned the chemical shift values to some of the carbons differently from what we assigned for **3**. Tan et al. \[[@B20-marinedrugs-15-00139]\] assigned the carbon signal at δ~C~ 108.7 to C-9a/9a′ (i.e., C-14/14′ for the numbering used by Tan et al.) instead of C-4a/4′a (i.e., C-13/13′ for the numbering used by Tan et al.) and the carbon signal at δ~C~ 131.8 to C-4a/4′a (i.e., C-13/C-13′ for the numbering used by Tan et al.) instead of C-9a/9a′ (i.e., C-13/C-13′ for the numbering used by Tan et al.). This assignment seems to be incorrect since the chemical shift values of C-4a and C-10a of a series of anthraquinones with the hydroxyl groups on C-4 and C-5 isolated from this extract, i.e., emodin (**4a**), citreorosein (**4c**), fallacinol (**4d**) and rheoemodin (**4e**), are ca. 108 and 115 ppm, which is far from 133 ppm proposed by Tan et al. \[[@B19-marinedrugs-15-00139]\]. Consequently, we are convinced that the structure proposed for compound 2240A is not correct. Interestingly, Tan et al. \[[@B19-marinedrugs-15-00139]\] reported 2240A as dextrorotatory, displaying \[α$\rbrack_{\text{D}}^{20}$ +62.50 (*c* 0.08, dioxin). On the contrary, **3** is levorotatory having \[α$\rbrack_{\text{D}}^{20}$ −40 (*c* 0.05, dioxin) and −100 (*c* 0.05, MeOH), respectively. Since **3** can be considered as a bridged biphenyl, it can have a phenomenon of atropisomerism due to a restricted rotation of the phenyl rings around the C-2/C-2′ bond. Therefore, **3** and compound 2240A, previously reported by Tan et al. \[[@B19-marinedrugs-15-00139]\] are different and could probably be atropisomers.

The structure of **3** can be viewed as a dimer of helminthosporin, an anthraquinone previously isolated from the subterranean stems of *Aloe saponaria* Haw. \[[@B21-marinedrugs-15-00139]\], and also from the roots of *Berchemia floribunda* \[[@B22-marinedrugs-15-00139]\].

The structures of the other known compounds, i.e., palmitic acid, ergosta-4,6,8(14),22-tetraen-3-one, ergosterol-5,8-endoperoxide, emodin (**4a**), questinol (**4b**), citreorosein (**4c**), fallacinol (**4d**), rheoemodin (**4e**) and secalonic acid A (**5**) were elucidated by analysis of their ^1^H, ^13^C NMR and HRMS spectra, and a rotation when the compounds have stereogenic carbons as well as by comparison of these spectroscopic data with those reported in the literature.

Emodin (**4a**), questinol (**4b**), citreorosein (**4c**), fallacinol (**4d**), rheoemodin (**4e**), and secalonic acid A (**5**) were tested for their anti-obesity activity using the zebrafish Nile red assay. The results showed that only the anthraquinones questinol (**4b**) and citreorosein (**4c**) had significant anti-obesity activity. Questinol (**4b**) and citreorosein (**4c**) reduced \>60% and \>90% of the stained lipids with the IC~50~ values of 0.95 and 0.17 µM, respectively. The positive control resveratrol (REV) had an IC~50~ value of 0.6 µM ([Figure 7](#marinedrugs-15-00139-f007){ref-type="fig"}). Interestingly, emodin (**4a**) and secalonic acid A (**5**) caused toxicity (death) for all exposed zebrafish larvae after 24 h, while fallacinol (**4d**) and rheoemodin (**4e**) did not have any significant effects ([Figure 8](#marinedrugs-15-00139-f008){ref-type="fig"}).

It is interesting to observe that questinol (**4b**), citreorosein (**4c**) and fallacinol (**4d**) are structurally similar, all having a hydroxymethyl group on C-6 and a hydroxyl group on C-8. Replacing the hydroxyl group on C-1 by a methoxyl group, as in questinol (**4b**), diminishes the activity whereas replacing the hydroxyl group on C-3 with a methoxyl group, as in fallacinol (**4d**), completely removes the anti-obesity activity. Therefore, it seems that the hydroxymethyl group on C-6 and the hydroxyl groups on C-3 and C-8 are necessary for the anti-obesity activity of the polyhydroxy anthraquinones.

3. Experimental Section {#sec3-marinedrugs-15-00139}
=======================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-15-00139}
------------------------------------

Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations were measured on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent, UK). Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from Thermo Scientific (Waltham, MA, USA) with Smart OMNI-Transmission accessory (Software 188 OMNIC. ^1^H and ^13^C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument (Bruker Biosciences Corporation, Billerica, MA, USA) operating at 300.13 and 75.4 Hz or at 500.13 and 125.4 MHz, respectively. High resolution mass spectra were measured with a Waters Xevo QToF mass spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC system. A Merck (Darmstadt, Germany) silica gel GF~254~ was used for preparative TLC, and a Merck Si gel 60 (0.2--0.5 mm) was used for column chromatography.

3.2. Fungal Material {#sec3dot2-marinedrugs-15-00139}
--------------------

The strain KUFA 0207 was isolated from the marine sponge *Stylissa flabelliformis*, which was collected by scuba diving at a depth of 10--15 m, from the coral reef at Samaesarn Island (12°34′36.64″ N 100°56′59.69″ E) in the Gulf of Thailand, Chonburi Province, in April 2014. The sponge was washed with 1% sodium hypochlorite solution for 1 min, followed by sterilized seawater three times, and then dried on sterile filter paper under a laminar flow hood, cut into small pieces (5 × 5 mm), and placed on malt extract agar (MEA) plates containing 70% seawater and 300 mg/L of streptomycin sulfate. The plates were incubated at 28 °C for seven days, after which the hyphal tips were transferred onto a slant MEA and maintained as pure culture for further identification. The fungus was identified as *Talaromyces stipitatus* C.R. Benj., based on morphological characteristics, and was also confirmed by analysis sequence of the internal transcribed spacer (ITS) gene according to the procedure previously described by us \[[@B23-marinedrugs-15-00139]\]. Its gene sequences were deposited in GenBank with accession number KU500028. The pure cultures were deposited as KUFA 0207 at Kasetsart University Fungal Collection, Department of Plant Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand. The fungus was cultured for one week at 28 °C in 10 Petri dishes (i.d. 90 mm) containing 25 mL of MEA. In order to obtain the mycelial suspension, the mycelial plugs were transferred to two 500 mL Erlenmeyer flasks containing 200 mL of potato dextrose broth, and then incubated on a rotary shaker at 120 rpm at 28 °C for one week. Fifty 1000 mL Erlenmeyer flasks, each containing 300 g of cooked rice, were autoclaved at 121 °C for 15 min, and then inoculated with 20 mL of mycelial suspension of *T. stipitatus* and incubated at 28 °C for 30 days, after which the moldy rice was macerated in ethyl acetate (25 L total) for seven days, and then filtered. The ethyl acetate solution was concentrated under reduced pressure to yield 65.6 g of crude ethyl acetate extract.

3.3. Extraction and Isolation {#sec3dot3-marinedrugs-15-00139}
-----------------------------

The crude ethyl acetate (35 g) was applied on a column of silica gel (335 g), and eluted with mixtures of petrol-CHCl~3~ and CHCl~3~-Me~2~CO, 250 mL fractions were collected as follows: Frs 1--133 (petrol-CHCl~3~, 1:1), 134--249 (petrol-CHCl~3~, 3:7), 250--314 (petrol-CHCl~3~, 1:9), 315--440 (CHCl~3~-Me~2~CO, 9:1), 441--511 (CHCl~3~-Me~2~CO, 7:1), 512--546 (CHCl~3~-Me~2~CO, 1:1). Frs 156--170 were combined (382.7 mg) and crystallized in methanol to give palmitic acid (20 mg). Frs 171--182 were combined (370 mg) and purified by TLC (silica gel G~254~, CHCl~3~-petrol-EtOAc-HCO~2~H, 16:3:1:0.01) to give **1** (10.5 mg), palmitic acid (21.7 mg) and ergosta-4,6,8(14),22-tetraen-3-one (23.3 mg). Frs 220--250 were combined (201.5 mg) and crystallized in MeOH to give ergosta-4,6,8(14),22-tetraen-3-one (19.6 mg). Frs 315--317 were combined (4.53 g) and applied over a column chromatography of silica gel (35 g) and eluted with mixture of petrol-CHCl~3~ and CHCl~3~-Me~2~CO, wherein 250 mL fractions were collected as follows: sfrs 1--101 (petrol-CHCl~3~, 1:1), 102-170 (petrol-CHCl~3~, 3:7), 171--296 (petrol-CHCl~3~, 1:9), 297--311 (CHCl~3~-Me~2~CO, 9:1). Sfrs 19--38 were combined (329 mg) and applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of CHCl~3~:MeOH, to give forty 15 mL ssfrs. Ssfrs 8--37 were combined and purified by TLC (silica gel G~254~, CHCl~3~-petrol-EtOAc-HCO~2~H, 80:16.5:3.5:0.1) to give **2** (12.2 mg). Sfrs 229--296 were combined (179 mg) and purified by TLC (silica gel G~254~, CHCl~3~-petrol-EtOAc-HCO~2~H, 80:15:5:0.1) to give emodin (**4a**, 10 mg). Frs 318--330 were combined (3.77 g) and applied over a column chromatography of silica gel (100 g) and eluted with a mixture of petrol-CHCl~3~ and CHCl~3~-Me~2~CO, wherein 100 mL fractions were collected as follows: sfrs 1--118 (petrol-CHCl~3~, 1:1), 199--277 (petrol-CHCl~3~, 3:7), 278--289 (petrol-CHCl~3~, 1:9), 290--471 (CDCl~3~), 472--589 (CHCl~3~-Me~2~CO, 9:1), 590--633 (CHCl~3~-Me~2~CO, 7:3). Sfrs 238--395 were combined (473.7 mg) and crystallized in a mixture of CHCl~3~ and petrol to give ergosterol-5,8-endoperoxide (22 mg). Sfrs 477 (146.2 mg) was crystallized in a mixture of CHCl~3~ and petrol to give a reddish orange solid of **3** (9 mg). Sfrs 510--524 were combined (53 mg) and crystallized in CHCl~3~ to give yellow solid of fallacinol (**4d**, 21 mg). Frs 332--345 were combined (60.0 mg) and crystalized in a mixture of CHCl~3~ and MeOH to give 15.2 mg of secalonic acid A. Frs 355--365 were combined (103.0 mg) and crystalized in a mixture of CHCl~3~ and MeOH to an additional 10.5 mg of secalonic acid A, whereas the mother liquor was further purified by TLC (silica gel G~254~, CHCl~3~-Me~2~CO-HCO~2~H, 4:1:0.01) to give 8.5 mg of citreorosein (**4c**). Frs 392--440 were combined (316 mg) and crystallized in Me~2~CO to give questinol (**4b**, 10.7 mg). Frs 443--450 were combined and crystallized in Me~2~CO to give rheoemodin (**4e**, 2.5 mg).

### 3.3.1. Talarosterone (**1**): (7*R*,8*R*)-Epoxyergosta-4,22-dien-3,6-dione {#sec3dot3dot1-marinedrugs-15-00139}

White crystal; mp 146--148 °C; \[α$\rbrack_{\text{D}}^{20}$ +204 (*c* 0.04, CHCl~3~); IR (KBr) υ~max~ 2956, 2873, 1689, 1670, 1593, 1458, 1411, 1276, 1260 cm^−1^; For ^1^H and ^13^C spectroscopic data (CDCl~3~, 300.13 and 75.14 MHz), see [Table 1](#marinedrugs-15-00139-t001){ref-type="table"}; (+)-HRESIMS *m*/*z* 425.3056 \[M + H\]^+^ (calcd. for C~28~H~41~O~3~, 425.3056).

### 3.3.2. *Bis*(1,4,5-Trihydroxy-7-methylanthraquinone) (**3**) {#sec3dot3dot2-marinedrugs-15-00139}

Reddish orange solid; mp 258--260 °C; \[α$\rbrack_{\text{D}}^{20}$ −100 (*c* 0.05, MeOH) and −40 (*c* 0.05, dioxin); IR (KBr) υ~max~ 3463, 2359, 1622, 1550, 1480, 1457, 1247, 1207 cm^−1^; For ^1^H and ^13^C spectroscopic data (CDCl~3~, 500.13 and 75.4 MHz), see [Table 2](#marinedrugs-15-00139-t002){ref-type="table"}; (+)-HRESIMS *m*/*z* 539.0942 \[M + H\]^+^ (calcd. for C~30~H~19~O~10~, 539.0978).

3.4. X-ray Crystal Structure of Compounds ***1*** and ***20*** {#sec3dot4-marinedrugs-15-00139}
--------------------------------------------------------------

Diffraction data were collected at 293 K with a Gemini PX Ultra equipped with CuK~α~ radiation (Oxford Diffraction, Abingdon, Oxfordshire, UK) (λ = 1.54184 Å). The structures were solved by direct methods using SHELXS-97 and refined with SHELXL-97 \[[@B24-marinedrugs-15-00139]\]. Carbon and oxygen atoms were refined anisotropically. Hydrogen atoms were either placed at their idealized positions using appropriate HFIX instructions in SHELXL, and included in subsequent refinement cycles, or were directly found from difference Fourier maps and were refined freely with isotropic displacement parameters. Full details of the data collection and refinement and tables of atomic coordinates, bond lengths and angles, and torsion angles have been deposited with the Cambridge Crystallographic Data Centre (CCDC).

Talarosterone (**1**). Crystals were orthorhombic, space group C222~1~, cell volume 5091.3(10) Å^3^ and unit cell dimensions *a* = 8.4602(5) Å, *b* = 12.407(2) Å and *c* = 48.504(5) Å. The refinement converged to *R* (all data) = 9.72% and *wR*~2~ (all data) = 15.83%. CCDC 1527335.

Cyathiserone (**2**). Crystals were monoclinic, space group P2~1~, cell volume 1278.36(8) Å^3^ and unit cell dimensions *a* = 6.6142(2) Å, *b* = 6.46731(19) Å and *c* = 29.8941(13) Å and angle β = 91.419(4)° (uncertainties in parentheses). The refinement converged to *R* (all data) = 6.96% and *wR*~2~ (all data) = 14.86%. CCDC 1527349.

3.5. Anti-Obesity Assay {#sec3dot5-marinedrugs-15-00139}
-----------------------

Compounds **4a**--**e** and **5** were dissolved in DMSO at a concentration of 5 mM and stored at −20 °C until analyses. Anti-obesity activity of the compounds was analyzed with the zebrafish Nile red assay as described in Jones et al. \[[@B18-marinedrugs-15-00139]\] with some modifications. Zebrafish adults and larvae were maintained under standard conditions at 28 °C as defined in the zebrafish book available at the ZFIN database (<https://zfin.org/>). In brief, zebrafish embryos were raised from 1 DPF (days post fertilization) in egg water (60 µg/mL marine sea salt dissolved in distilled H~2~O) with 200 µM PTU (1-phenyl-2-thiourea) to inhibit pigmentation. From 3 DPF to 5 DPF, zebrafish larvae were exposed to compounds at a final concentration of 5 µM with daily renewal of water and compounds in a 24-well plate with a density of 10--12 larvae/well. A solvent control (0.1% DMSO) and positive control (REV, resveratrol, final concentration 50 µM) were included in the assay. Lipids were stained with Nile red overnight at the final concentration of 10 ng/mL. For imaging, the larvae were anaesthetized with tricaine (MS-222, 0.03%) for 5 min and fluorescence analyzed with a fluorescence microscope (Leica DM6000B, Wetzlar, Germany). Fluorescence intensity was quantified in individual zebrafish larvae by ImageJ (<http://rsb.info.nih.gov/ij/index.html>).

4. Conclusions {#sec4-marinedrugs-15-00139}
==============

The ethyl acetate extract from the culture of the marine sponge-associated fungus *Talaromyces stipitatus* KUFA 0207 furnished a new ergosterol derivative (**1**), a new *bis*-anthraquinone derivative (**3**), and ten known compounds including palmitic acid, ergosta-4,6,8(14),22-tetraen-3-one, ergosterol-5,8-endoperoxide, cyathisterone (**2**), and the previously reported anthraquinones emodin (**4a**), questinol (**4b**), citreorosein (**4c**), fallacinol (**4d**), rheoemodin (**4e**), as well as secalonic acid A (**5**). The stereochemistry of the stereogenic carbons of compounds **1** and **2** was established by X-ray analysis. Compounds **4a**--**e** and **5** were tested for their anti-obesity activity by the zebrafish Nile red assay using resveratrol as a positive control. Citreorosein (**4c**) exhibited strong anti-obesity activity (IC~50~ = 0.17 μM), while questinol (**4b**) showed moderate activity (IC~50~ = 0.95 μM) in this test system. Analysis of the structures of the anthraquinones tested revealed that the hydroxymethyl group on C-6 and the hydroxyl groups on C-3 and C-8 are required for the anti-obesity activity. The results obtained from this study suggested that marine-derived fungi of the genus *Talaromyces* can be a promising source of compounds with potential anti-obesity activity.
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![Secondary metabolites from *Talaromyces stipitatus* KUFA 0207.](marinedrugs-15-00139-g001){#marinedrugs-15-00139-f001}
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![Anti-obesity activity of compounds **4a**--**e** and **5** in the zebrafish larvae Nile red assay. The solvent control had 0.1% DMSO and the positive control received 50 µM resveratrol (REV). Values are presented as mean fluorescence intensity (MFI) relative to the DMSO group, and are derived from 10 to 12 individual larvae per treatment group. Statistical differences to the solvent control are indicated with asterisks, \*\*\* = *p* \< 0.001.](marinedrugs-15-00139-g007){#marinedrugs-15-00139-f007}

![Representative images of the zebrafish Nile red assay. The upper images show the overlay of the fluorescence and phase contrast; the lower images show the mean fluorescence intensity (MFI) given as black and white picture. DMSO, solvent control 0.1%.](marinedrugs-15-00139-g008){#marinedrugs-15-00139-f008}
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###### 

^1^H and ^13^C NMR (CDCl~3~, 300.13 MHz and 75.4 MHz) and HMBC assignment for **1**.

  Position   δ~C~, Type    δ~H~, (*J* in Hz)      COSY       ROESY         HMBC
  ---------- ------------- ---------------------- ---------- ------------- ------------------
  1α         37.1, CH~2~   1.81, m                                         
  β                        2.18, m                                         
  2α         33.8, CH~2~   2.50,m                 H-1                      
  β                        2.64, dd (17.9, 7.2)   H-1                      
  3          199.5, CO     \-                                              
  4          129.2, CH     6.66, d (0.8)          \-                       C-2, 3, 5
  5          155.0, C      \-                                              
  6          195.9, CO     \-                                              
  7          56.1, CH      3.20, s                \-         H-9, 14, 15   C-5, 6, 8, 14
  8          66.2, C       \-                                              
  9          43.9, CH      1.90, m                                         
  10         36.8, C       \-                                              
  11         20.7, CH~2~   1.85, m                                         
  12         39.0, CH~2~   1.21, m; 1.40, m                                
  13         44.3, C       \-                                              
  14         51.8, CH      1.94, m                                         
  15         18.7, CH~2~   1.25, m                                         
  16         27.7, CH~2~   1.34, m; 1.75, m                                
  17         56.0, CH      1.30, m                                         
  18         12.4, CH~3~   0.89, s                                         C-12, 13, 14, 17
  19         21.8, CH~3~   1.50, s                \-         1β, 2β        C-1, 5, 9
  20         40.0, CH      2.04, m                                         
  21         21.0 CH~3~    1.04, d (6.8)          H-20                     C-17, 20, 22
  22         135.0, CH     5.15, dd (15.3, 7.3)   H-20, 23                 C-21, 24
  23         132.5, CH     5.25, dd (15.3, 8.0)   H-22, 24                 C-20, 24, 25, 26
  24         42.8, CH      1.85, m                                         C-22, 23
  25         33.0, CH      1.48, m                                         
  26         17.6, CH~3~   0.92, d (6.8)          H-24                     C-23, 24, 25
  27         20.0, CH~3~   0.82, d (6.8)          H-25                     C-24, 25, 28
  28         19.6 CH~3~    0.84, d (6.8)          H-25                     C-24, 25, 27
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###### 

^1^H and ^13^C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment for **3**.

  Position       δ~C~, Type    δ~H~, (*J* in Hz)     COSY                  HMBC
  -------------- ------------- --------------------- --------------------- --------------------------------------
  1 (1′)         164.3, C      \-                                          
  2 (2′)         123.5, C      \-                                          
  3 (3′)         107.2, CH     6.73, s               \-                    C-1 (1′), 4 (4′), 2 (2′), 4a (4′a)
  4 (4′)         108.9, C      \-                                          
  4a (4′a)       108.9, C      \-                                          
  5 (5′)         161.1, C      \-                                          
  6 (6′)         123.6, CH     7.15, dd (1.0, 0.5)   H-8 (8′), Me-7 (7′)   C-5 (5′), 7 (7′), 8 (8′), 10a (10′a)
  7 (7′)         148.2, C      \-                                          
  8 (8′)         120.5, CH     7.28, dd (1.0, 0.5)   H-6 (6′), Me-7 (7′)   C-6 (6′), 7 (7′), 9 (9′), 10a (10′a)
  8a (8′a)       131.3, C \*   \-                                          
  9 (9′)         182.1, CO     \-                                          
  9a (9′a)       133.2, C \*   \-                                          
  10 (10′)       189.6, CO     \-                                          
  10a (10′a)     113.1, C      \-                                          
  CH~3~-7 (7′)   21.5, CH~3~   2.33, s               H-6 (6′), 8 (8′)      C-6 (6′), 7 (7′), 8 (8′)
  OH-4 (4′)      \-            12.79, s              \-                    C-3 (3′), 4 (4′), 4a (4′a)
  OH-5 (5′)      \-            12.04, s              \-                    C-5 (5′), 6 (6′), 10a (10′a)

\* can be interchanged.
